Less than two weeks after rejecting Sanofi’s investigational multiple sclerosis drug, the FDA has publicly shared the ...

The team, consisting of researchers from University College London (UCL) and Queen Square Analytics, analysed 634 patients ...

For the first time, UCL researchers have used AI to identify two biologically distinct forms of multiple sclerosis ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

Last month, the FDA declined to approve Sanofi’s tolebrutinib for a specific form of multiple sclerosis. In a recently ...

Exclusive: Scientists uncovered biological strands using artificial intelligence and hope discovery will revolutionise treatment ...

By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...

Collagen is the most abundant protein in the human body and has an important role in healthy tissue as well as in a range of prevalent diseases. Medical research and diagnostics hence call for means ...

The faster patients can be diagnosed with multiple sclerosis the sooner they can begin taking the powerful medications that can prevent further brain damage. This fall, Lancet Neurology published new ...

Why does Mr. “Inject Disinfectants” believe he has the credibility or expertise to guide the public on health matters?

Two new sub-types of multiple sclerosis (MS) were discovered by researchers from Queen Square Analytics and University ...

Lipoic acid offers no improvements in walking speed or other outcomes in patients with progressive multiple sclerosis ...